The following video presentation provides a brief introduction to the BMT CTN 0702 trial and provides an update on the CALGB 100104 trial for patients with multiple myeloma.
NOTE: the CALGB 100104 study closed to accrual in July 2009; the BMT CTN 0702 study will be open for accrual in the spring of 2010 with an anticipated accrual period of three years.
For more information, please contact us at cgurgol@emmes.com.
BMT CTN 0702: A Trial of Single Autologous Transplant with or without
Consolidation Therapy with Lenalidomide Maintenance for Patients with
Multiple Myeloma Investigators are invited to participate in the BMT CTN
0702 trial and encouraged to forward this video link to interested
colleagues. For more information, please contact us at
cgurgol@emmes.com.